AMENDED AND RESTATED LICENSE AGREEMENT by and between NAPO PHARMACEUTICALS, INC. and JAGUAR ANIMAL HEALTH, INC. originally dated as of January 27, 2014 and amended and restated as of August 6, 2014License Agreement • August 27th, 2014 • Jaguar Animal Health, Inc. • Pharmaceutical preparations • California
Contract Type FiledAugust 27th, 2014 Company Industry JurisdictionThis Amended and Restated License Agreement (this “Agreement”) is made originally as of January 27, 2014 (the “Effective Date”) and amended and restated as of August 6, 2014 (the “Restatement Date”), by and between Napo Pharmaceuticals, Inc., a Delaware corporation, having offices located at 185 Berry Street, Suite 1300, San Francisco, California 94107 (“Napo”), and Jaguar Animal Health, Inc., a Delaware corporation, having offices located at 185 Berry Street, Suite 1300, San Francisco, California 94107 (“JAH”). Napo and JAH are sometimes referred to herein individually as a “Party” and collectively as the “Parties.” All capitalized terms used herein are defined either in the Section 1 below or within the context of the section where the term is first used in this Agreement. This Agreement as amended and restated as of the Restatement Date amends and restates (and replaces and supersedes) in its entirety this Agreement as originally executed, to the extent of any conflict, all of the f
AMENDED AND RESTATED LICENSE AGREEMENT by and between NAPO PHARMACEUTICALS, INC. and JAGUAR ANIMAL HEALTH, INC. originally dated as of January 27, 2014 and amended and restated as of August 6, 2014License Agreement • August 11th, 2014 • Jaguar Animal Health, Inc. • Pharmaceutical preparations • California
Contract Type FiledAugust 11th, 2014 Company Industry JurisdictionThis Amended and Restated License Agreement (this “Agreement”) is made originally as of January 27, 2014 (the “Effective Date”) and amended and restated as of August 6, 2014 (the “Restatement Date”), by and between Napo Pharmaceuticals, Inc., a Delaware corporation, having offices located at 185 Berry Street, Suite 1300, San Francisco, California 94107 (“Napo”), and Jaguar Animal Health, Inc., a Delaware corporation, having offices located at 185 Berry Street, Suite 1300, San Francisco, California 94107 (“JAH”). Napo and JAH are sometimes referred to herein individually as a “Party” and collectively as the “Parties.” All capitalized terms used herein are defined either in the Section 1 below or within the context of the section where the term is first used in this Agreement. This Agreement as amended and restated as of the Restatement Date amends and restates (and replaces and supersedes) in its entirety this Agreement as originally executed, to the extent of any conflict, all of the f